Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1000, Issue , 2015, Pages 95-104

  Willmann, Lucas ^a   Schlimpert, Manuel ^a   Halbach, Sebastian ^a   Erbes, Thalia ^b   Stickeler, Elmar ^b   Kammerer, Bernd ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Breast cancer; GC EI MS; Metabolic profiling; Metabolomics

Indexed keywords

CELL CULTURE; CYTOLOGY; DISEASES; METABOLISM;

BIOCHEMICAL PATHWAY; BREAST CANCER; BREAST CANCER CELLS; CENTRAL METABOLISMS; GC-EI-MS; METABOLIC PATHWAYS; METABOLIC PROFILING; METABOLOMICS;

CELLS;

CELL EXTRACT; FUMARATE HYDRATASE; LACTIC ACID; SUCCINATE DEHYDROGENASE; VASOACTIVE INTESTINAL POLYPEPTIDE; TUMOR MARKER;

ADHERENT CELL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL DISRUPTION; CITRIC ACID CYCLE; CLUSTER ANALYSIS; FEMALE; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN CELL; MASS FRAGMENTOGRAPHY; METABOLOMICS; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; UPREGULATION; ADULT; BREAST TUMOR; CLASSIFICATION; METABOLISM; METABOLOME; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

ADULT; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METABOLOME; METABOLOMICS; MIDDLE AGED;

EID: 84937855104     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.07.021     Document Type: Article

References (60)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90. 10.3322/caac.20107.
2. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899. 10.1038/nrc1478.
3. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95. 10.1038/nrc2981.
4. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 2002, 48:155-171.
5. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genom. 2001, 2:155-168. 10.1002/cfg.82.
6. Oakman C., Tenori L., Biganzoli L., Santarpia L., Cappadona S., Luchinat C., et al. Uncovering the metabolomic fingerprint of breast cancer. Int. J. Biochem. Cell Biol. 2011, 43:1010-1020. 10.1016/j.biocel.2010.05.001.
7. McShane L.M., Hayes D.F. Publication of tumor marker research results: the necessity for complete and transparent reporting. J. Clin. Oncol. 2012, 30:4223-4232. 10.1200/jco.2012.42.6858.
8. Hu X., Stern H.M., Ge L., O'Brien C., Haydu L., Honchell C.D., et al. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol. Cancer Res. 2009, 7:511-522. 10.1158/1541-7786.MCR-08-0107.
9. Holliday D.L., Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011, 13:215. 10.1186/bcr2889.
10. Androulakis I.P., Yang E., Almon R.R. Analysis of time-series gene expression data: methods, challenges, and opportunities. Ann. Rev. Biomed. Eng. 2007, 9:205-228. 10.1146/annurev.bioeng.9.060906.151904.
11. Giersch C. Determining elasticities from multiple measurements of flux rates and metabolite concentrations. Application of the multiple modulation method to a reconstituted pathway. Eur. J. Biochem. 1995, 227:194-201.
12. Bullinger D., Neubauer H., Fehm T., Laufer S., Gleiter C.H., Kammerer B. Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling. BMC Biochem. 2007, 8:25. 10.1186/1471-2091-8-25.
13. Willmann L., Erbes T., Krieger S., Trafkowski J., Rodamer M., Kammerer B. Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism. Anal. Bioanal. Chem. 2015, 10.1007/s00216-015-8516-6.
14. Cuperlovic-Culf M., Chute I.C., Culf A.S., Touaibia M., Ghosh A., Griffiths S., et al. 1H NMR metabolomics combined with gene expression analysis for the determination of major metabolic differences between subtypes of breast cell lines. Chem. Sci. 2011, 2:2263. 10.1039/c1sc00382h.
15. Fiehn O., Kopka J., Dörmann P., Altmann T., Trethewey R.N., Willmitzer L. Metabolite profiling for plant functional genomics. Nat. Biotechnol. 2000, 18:1157-1161. 10.1038/81137.
16. Lisec J., Schauer N., Kopka J., Willmitzer L., Fernie A.R. Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat. Protoc. 2006, 1:378-396. 10.1038/nprot.2006.59.
17. Fiehn O. Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry. Trends Anal. Chem. 2008, 27:261-269. 10.1016/j.trac.2008.01.007.
18. Stein S.E. An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J. Am. Soc. Mass Spectrom. 1999, 10:770-781. 10.1016/S1044-0305(99)47-1.
19. Stein S.E., Scott D.R. Optimization and testing of mass spectral library search algorithms for compound identification. J. Am. Soc. Mass Spectrom. 1994, 5:859-866. 10.1016/1044-0305(94)87009-8.
20. Schauer N., Steinhauser D., Strelkov S., Schomburg D., Allison G., Moritz T., et al. GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS Lett. 2005, 579:1332-1337. 10.1016/j.febslet.2005.01.029.
21. Halket J.M. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J. Exp. Bot. 2004, 56:219-243. 10.1093/jxb/eri069.
22. Jolliffe I.T. Principal Component Analysis 2002, Springer, New York, (accessed 11.02.15). http://site.ebrary.com/id/10047693.
23. Barker M., Rayens W. Partial least squares for discrimination. J. Chemom. 2003, 17:166-173. 10.1002/cem.785.
24. Xia J., Sinelnikov I.V., Wishart D.S. MetATT: a web-based metabolomics tool for analyzing time-series and two-factor datasets. Bioinformatics 2011, 27:2455-2456. 10.1093/bioinformatics/btr392.
25. Xia J., Mandal R., Sinelnikov I.V., Broadhurst D., Wishart D.S. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012, 40:W127-W133. 10.1093/nar/gks374.
26. Rohn H., Junker A., Hartmann A., Grafahrend-Belau E., Treutler H., Klapperstück M., et al. VANTED v2: a framework for systems biology applications. BMC Syst. Biol. 2012, 6:139. 10.1186/1752-0509-6-139.
27. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D., Brenz R., McGrath C.M., et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990, 50:6075-6086.
28. Subik K., Lee J.F., Baxter L., Strzepek T., Costello D., Crowley P., et al. The expression patterns of ER, PR HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer (Auckland) 2010, 4:35-41.
29. Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336:1040-1044. 10.1126/science.1218595.
30. Fiehn O. Metabolite profiling in arabidopsis. Methods Mol. Biol. 2006, 323:439-447. 10.1385/1-59745-003-0:439.
31. Styczynski M.P., Moxley J.F., Tong L.V., Walther J.L., Jensen K.L., Stephanopoulos G.N. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Anal. Chem. 2007, 79:966-973. 10.1021/ac0614846.
32. Kind T., Wohlgemuth G., Lee D.Y., Lu Y., Palazoglu M., Shahbaz S., et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal. Chem. 2009, 81:10038-10048. 10.1021/ac9019522.
33. Kopka J., Schauer N., Krueger S., Birkemeyer C., Usadel B., Bergmüller E., et al. GMD@CSB.DB: the golm metabolome database. Bioinformatics 2005, 21:1635-1638. 10.1093/bioinformatics/bti236.
34. NIST/EPA/NIH NIST Mass Spectral Library 2011, National Institute of Standards and Technology, USA.
35. Hutschenreuther A., Kiontke A., Birkenmeier G., Birkemeyer C. Comparison of extraction conditions and normalization approaches for cellular metabolomics of adherent growing cells with GC-MS. Anal. Methods 2012, 4:1953. 10.1039/c2ay25046b.
36. Teng Q., Huang W., Collette T.W., Ekman D.R., Tan C. A direct cell quenching method for cell-culture based metabolomics. Metabolomics 2009, 5:199-208. 10.1007/s11306-008-0137-z.
37. Dettmer K., Nürnberger N., Kaspar H., Gruber M.A., Almstetter M.F., Oefner P.J. Metabolite extraction from adherently growing mammalian cells for metabolomics studies: optimization of harvesting and extraction protocols. Anal. Bioanal. Chem. 2011, 399:1127-1139. 10.1007/s00216-010-4425-x.
38. Halama A., Riesen N., Möller G., Hrabě de Angelis M., Adamski J. Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine. J. Int. Med. 2013, 274:425-439. 10.1111/joim.12117.
39. Lai H.-S., Lee J.-C., Lee P.-H., Wang S.-T., Chen W.-J. Plasma free amino acid profile in cancer patients. Semin. Cancer Biol. 2005, 15:267-276. 10.1016/j.semcancer.2005.04.003.
40. Shen J., Yan L., Liu S., Ambrosone C.B., Zhao H. Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. Trans. Oncol. 2013, 6:757-765.
41. Miyagi Y., Higashiyama M., Gochi A., Akaike M., Ishikawa T., Miura T., et al. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 2011, 6:e24143. 10.1371/journal.pone.0024143.
42. Kim J., Dang C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006, 66:8927-8930. 10.1158/0008-5472.CAN-06-1501.
43. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
44. Morin A., Letouzé E., Gimenez-Roqueplo A.-P., Favier J. Oncometabolites-driven tumorigenesis: from genetics to targeted therapy: oncometabolites-driven tumorigenesis. Int. J. Cancer 2014, 135:2237-2248. 10.1002/ijc.29080.
45. Pollard P.J., Brière J.J., Alam N.A., Barwell J., Barclay E., Wortham N.C., et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 2005, 14:2231-2239. 10.1093/hmg/ddi227.
46. Masson N., Ratcliffe P.J. Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways. Cancer Metab. 2014, 2:3. 10.1186/2049-3002-2-3.
47. Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H., et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998, 12:149-162.
48. Ullah M.S., Davies A.J., Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 2006, 281:9030-9037. 10.1074/jbc.M511397200.
49. Shi Role and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231. Oncol. Lett. 2010, 1. 10.3892/ol_00000115.
50. Chayangsu C., Kanjanasilp P., Malakorn S., Sahakitrungruang C., Tanasanvimon S., Sitthideatphaiboon P., et al. P0227 utility of pre-treatment serum amphiregulin in colorectal carcinoma. Eur. J. Cancer 2014, 50:e73. 10.1016/j.ejca.2014.03.271.
51. Gatza M.L., Kung H.-N., Blackwell K.L., Dewhirst M.W., Marks J.R., Chi J.-T. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes. Breast Cancer Res. 2011, 13:R62. 10.1186/bcr2899.
52. Frezza C., Zheng L., Tennant D.A., Papkovsky D.B., Hedley B.A., Kalna G., et al. Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival. PLoS One 2011, 6:e24411. 10.1371/journal.pone.0024411.
53. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197. 10.1016/j.cmet.2006.01.012.
54. Beckonert O., Monnerjahn J., Bonk U., Leibfritz D. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed. 2003, 16:1-11. 10.1002/nbm.797.
55. El-Sayed S., Bezabeh T., Odlum O., Patel R., Ahing S., MacDonald K., et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck 2002, 24:766-772. 10.1002/hed.10125.
56. Moreno A., López L.A., Fabra A., Arús C. 1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT-29 cells in nude mice spleen. NMR Biomed. 1998, 11:93-106.
57. Malcolm A., Wright S., Syms R.R.A., Dash N., Schwab M.-A., Finlay A. Miniature mass spectrometer systems based on a microengineered quadrupole filter. Anal. Chem. 2010, 82:1751-1758. 10.1021/ac902349k.
58. He X., Chen Q., Zhang Y., Lin J.-M. Recent advances in microchip-mass spectrometry for biological analysis. TrAC Trends Anal. Chem. 2014, 53:84-97. 10.1016/j.trac.2013.09.013.
59. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., et al. Laser capture microdissection. Science 1996, 274:998-1001. 10.1126/science.274.5289.998.
60. Prat A., Perou C.M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 2011, 5:5-23. 10.1016/j.molonc.2010.11.003.